SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option
K-Number: K250650 · 2025-04-15
Device Summary
Frequently Asked Questions
What is the SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option?
SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option is a medical device that received FDA 510(k) clearance on 2025-04-15. The listed applicant is Arineta , Ltd.. The 510(k) number is K250650.
When did SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option receive FDA 510(k) clearance?
SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option received FDA 510(k) clearance on 2025-04-15, under 510(k) number K250650.
Who is the listed applicant for SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option?
The FDA 510(k) record lists Arineta , Ltd. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option?
The FDA product code for SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option is JAK.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Arineta , Ltd. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: JAK)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.